Scynexis has resumed dosing of its vaginal yeast infection drug Brexafemme (ibrexafungerp) in a Phase III trial after a ...

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

The US-based START Center for Cancer Research (START) and OneOncology have collaborated to introduce three early-phase trial ...

Rein Therapeutics has dosed the first subject in a Phase II trial of LTI-03, its lead asset for treating idiopathic pulmonary ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

After Lykos' rejection from the FDA last year, companies trying to navigate the psychedelic drug trial sector face various ...

Edward Owen, Therapeutic Area Director of Oncology and Early Clinical Development at Genentech, discussed clinical trials decarbonisation at CTO West Coast. Credit: Athanasios Psimadis/ Arena ...

The collaboration supports BrainStorm’s preparation for its planned Phase IIIb trial. Credit: Pavel Kapysh / Shutterstock. US-based biotechnology company BrainStorm Cell Therapeutics has partnered ...